Microwave—assisted catalytic degradation efficiency of non-steroidal anti-inflammatory drug (NSAIDs) using magnetically separable magnesium ferrite (MgFe2O4) nanoparticles

Publications

Microwave—assisted catalytic degradation efficiency of non-steroidal anti-inflammatory drug (NSAIDs) using magnetically separable magnesium ferrite (MgFe2O4) nanoparticles

Author : Dr Mudassir Rafi

Year : 2025

Publisher : Springer Science and Business Media Deutschland GmbH

Source Title : Clean Technologies and Environmental Policy

Document Type :

Abstract

In the present study, we report the green synthesis of novel magnetically separable MgFe2O4 nanoparticles using Cajanus cajan (L.) Millsp leafs via combustion method. The MgFe2O4 were characterized by powder X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), vibrating sample magnetometer (VSM), and UV-diffuse reflectance (UV-DRS) spectroscopy. The crystalline structure of MgFe2O4 was confirmed via XRD studies and TEM showed that the MgFe2O4 NPs were distorted spherical particles with particle size ranging between 5 and 15 nm. UV-DRS study showed the optical band gap of MgFe2O4 NPs to be 1.8 eV. Microwave-assisted (MW) degradation of PCM-dolo drug using MgFe2O4 as catalyst was performed at different operating parameters such as time (30 min), drug concentration (PCM-dolo 50 mg/L), initial concentration of MgFe2O4 (0–110 mg/L), and microwave power (100–600 W) to obtained the degraded fragments of the drug. Experimental data was used to compute the degradation efficiency of PCM-dolo on MgFe2O4. The enhanced catalytic performance could be ascribed to the production of MW-induced active species, such as holes (h+), superoxide radicals (⋅O2−) and hydroxyl radicals (⋅OH) in the degradation process. A possible degradation mechanism and pathway was proposed.